Altria Group, Inc., through its subsidiaries, manufactures and sells cigarettes, oral tobacco products, and wine in the United States. It offers cigarettes primarily under the Marlboro brand; cigars principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. The company also produces and sells varietal and blended table wines, and sparkling wines under the Chateau Ste. Michelle and 14 Hands names; and imports and markets Antinori, Torres, and Villa Maria Estate wines, as well as Champagne Nicolas Feuillatte in the United States. In addition, it provides finance leasing services primarily in transportation, power generation, real estate, and manufacturing equipment industries. The company sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.
IPO Year:
Exchange: NYSE
Website: altria.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/16/2025 | $54.00 | Equal-Weight | Morgan Stanley |
| 12/6/2024 | $55.00 → $65.00 | Neutral → Buy | BofA Securities |
| 10/8/2024 | $44.50 → $48.00 | Neutral | Citigroup |
| 1/23/2024 | Sell | UBS | |
| 4/14/2023 | $52.00 | Buy | Stifel |
| 11/10/2022 | $38.00 | Neutral → Sell | UBS |
| 6/29/2022 | $53.00 → $36.00 | Equal Weight → Underweight | Barclays |
| 6/24/2022 | $47.00 → $43.00 | Underweight → Equal-Weight | Morgan Stanley |
| 6/8/2022 | $54.00 → $50.00 | Equal-Weight → Underweight | Morgan Stanley |
| 5/10/2022 | $58.00 → $53.00 | Outperform → Mkt Perform | Bernstein |
SC 13G/A - ALTRIA GROUP, INC. (0000764180) (Subject)
SC 13G/A - ALTRIA GROUP, INC. (0000764180) (Subject)
SC 13G/A - ALTRIA GROUP, INC. (0000764180) (Subject)
SC 13G/A - ALTRIA GROUP, INC. (0000764180) (Subject)
SC 13G - ALTRIA GROUP, INC. (0000764180) (Subject)
SC 13G/A - ALTRIA GROUP, INC. (0000764180) (Subject)
Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors declared a regular quarterly dividend of $1.02 per share, payable on January 10, 2025 to shareholders of record as of December 26, 2024. The ex-dividend date is December 26, 2024. View source version on businesswire.com: https://www.businesswire.com/news/home/20241210514136/en/
Altria Group, Inc. (NYSE:MO) today reports our 2024 third-quarter and nine-months business results and reaffirms our guidance for 2024 full-year adjusted diluted earnings per share (EPS). "Altria delivered outstanding results in the third quarter," said Billy Gifford, Altria's Chief Executive Officer. "The smokeable products segment delivered solid operating companies income growth behind the resilience of Marlboro, and in the oral tobacco products segment, our MST brands continued to drive profitability while on! maintained momentum in the marketplace. We also continued to reward shareholders through a growing dividend and share repurchases while making investments in pursuit of our Visio
Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors voted to increase our regular quarterly dividend by 4.1% to $1.02 per share versus the previous rate of $0.98 per share. The quarterly dividend is payable on October 10, 2024 to shareholders of record as of September 16, 2024. The ex-dividend date is September 16, 2024. The new annualized dividend rate is $4.08 per share, representing a dividend yield of 7.9% based on our closing stock price of $51.81 on August 21, 2024. Today's dividend increase is consistent with our progressive dividend goal that targets mid-single digits dividend per share growth annually through 2028. This increase marks the 59th dividend incr
Altria Group, Inc. (NYSE:MO) today reports our 2024 second-quarter and first-half business results and narrows our guidance for 2024 full-year adjusted diluted earnings per share (EPS). "Altria's momentum continues to build as we pursue our Vision to responsibly lead the transition of adult smokers to a smoke-free future," said Billy Gifford, Altria's Chief Executive Officer. "In the second quarter, our companies' innovative smoke-free products delivered strong share and volume performance, and we hit meaningful milestones that we believe set us up for future success. NJOY received the first and only marketing granted orders from the FDA for menthol e-vapor products, and we submitted PMTA
Altria Group, Inc. (Altria) (NYSE:MO) held our 2024 Annual Meeting of Shareholders (Annual Meeting) today. During the Annual Meeting, Billy Gifford, Altria's Chief Executive Officer, provided brief remarks and addressed shareholder questions. A copy of the presentation and a replay of the webcast are available on www.altria.com. Preliminary Voting Results The preliminary voting results from our shareholders at the Annual Meeting were as follows: elected to a one-year term each of the 10 nominees for our Board of Directors (Board) named in our 2024 Proxy Statement; ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2
Altria Group, Inc. (NYSE:MO) today reports our 2024 first-quarter business results and reaffirms our guidance for 2024 full-year adjusted diluted earnings per share (EPS). "We made meaningful progress in pursuit of our Vision, and our highly profitable traditional tobacco businesses continued to perform well in a challenging environment," said Billy Gifford, Altria's Chief Executive Officer. "In spite of the absence of an effective regulatory environment, we saw continued early momentum from NJOY and believe our businesses are on track to deliver against full-year plans." "We also demonstrated our continued commitment to maximizing the return on our investments and delivering strong sha
Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors declared a regular quarterly dividend of $0.98 per share, payable on April 30, 2024 to shareholders of record as of March 25, 2024. The ex-dividend date is March 22, 2024. View source version on businesswire.com: https://www.businesswire.com/news/home/20240228625112/en/
Altria Group, Inc. (NYSE:MO) today reports our 2023 fourth-quarter and full-year business results and provides our guidance for 2024 full-year adjusted diluted earnings per share (EPS). "It was a pivotal year for Altria as we made significant progress in pursuit of our Vision by enhancing our smoke-free product portfolio while our businesses performed well in a challenging environment," said Billy Gifford, Altria's Chief Executive Officer. "We grew adjusted diluted EPS by 2.3% and continued our long history of rewarding shareholders by delivering nearly $7.8 billion in dividends and share repurchases." "Our plans for 2024 include a continuation of our strategy to balance earnings growth
Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors declared a regular quarterly dividend of $0.98 per share, payable on January 10, 2024 to shareholders of record as of December 21, 2023. The ex-dividend date is December 20, 2023. View source version on businesswire.com: https://www.businesswire.com/news/home/20231206243816/en/
Altria Group, Inc. (NYSE:MO) today reports our 2023 third-quarter and nine-months business results and narrows our guidance for 2023 full-year adjusted diluted earnings per share (EPS). "Our highly profitable traditional tobacco businesses were resilient in a dynamic operating environment during the third quarter and first nine months, providing fuel for our business transformation and significant cash returns to our shareholders," said Billy Gifford, Altria's Chief Executive Officer. "I believe we have the appropriate strategies and people in place to execute our growth plans. I continue to believe that we can achieve our Vision and create long-term value for our shareholders." "We are
Altria Group, Inc. (Altria) (NYSE:MO) will host a live audio webcast on Thursday, January 30, 2025, at 9:00 a.m. Eastern Time to discuss its 2024 fourth-quarter and full-year business results. Altria will issue a press release containing its business results at approximately 7:00 a.m. Eastern Time the same day. The webcast can be accessed at altria.com. During the webcast, Billy Gifford, Altria's Chief Executive Officer, and Sal Mancuso, Altria's Chief Financial Officer, will discuss the Company's 2024 fourth-quarter and full-year business results and answer questions from the investment community and news media. The webcast will be in a listen-only mode. Pre-event registration is neces
Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors declared a regular quarterly dividend of $1.02 per share, payable on January 10, 2025 to shareholders of record as of December 26, 2024. The ex-dividend date is December 26, 2024. View source version on businesswire.com: https://www.businesswire.com/news/home/20241210514136/en/
Altria Group, Inc. (NYSE:MO) today reports our 2024 third-quarter and nine-months business results and reaffirms our guidance for 2024 full-year adjusted diluted earnings per share (EPS). "Altria delivered outstanding results in the third quarter," said Billy Gifford, Altria's Chief Executive Officer. "The smokeable products segment delivered solid operating companies income growth behind the resilience of Marlboro, and in the oral tobacco products segment, our MST brands continued to drive profitability while on! maintained momentum in the marketplace. We also continued to reward shareholders through a growing dividend and share repurchases while making investments in pursuit of our Visio
Altria Group, Inc. (Altria) (NYSE:MO) will host a live audio webcast on Thursday, October 31, 2024, at 9:00 a.m. Eastern Time to discuss its 2024 third-quarter and nine-months business results. Altria will issue a press release containing its business results at approximately 7:00 a.m. Eastern Time the same day. The webcast can be accessed at altria.com. During the webcast, Billy Gifford, Altria's Chief Executive Officer, and Sal Mancuso, Altria's Chief Financial Officer, will discuss the Company's 2024 third-quarter and nine-months business results and answer questions from the investment community and news media. The webcast will be in a listen-only mode. Pre-event registration is neces
Altria Group, Inc. (NYSE:MO) and its operating company NJOY today respond to the U.S. International Trade Commission (ITC) Administrative Law Judge's (ALJ) initial determination regarding the patent infringement complaint JUUL Labs, Inc. (JUUL) filed against NJOY. Last week, the ALJ provided notice of her initial determination supporting JUUL's allegations in its complaint and recommending an exclusion order that would prohibit the importation of NJOY ACE (ACE) into the United States. Altria and NJOY respectfully disagree with the ALJ's initial determination, and NJOY looks forward to presenting its position to the full ITC, which is expected to issue a final decision by December 23, 20
Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors voted to increase our regular quarterly dividend by 4.1% to $1.02 per share versus the previous rate of $0.98 per share. The quarterly dividend is payable on October 10, 2024 to shareholders of record as of September 16, 2024. The ex-dividend date is September 16, 2024. The new annualized dividend rate is $4.08 per share, representing a dividend yield of 7.9% based on our closing stock price of $51.81 on August 21, 2024. Today's dividend increase is consistent with our progressive dividend goal that targets mid-single digits dividend per share growth annually through 2028. This increase marks the 59th dividend incr
Altria Group, Inc. (NYSE:MO) today reports our 2024 second-quarter and first-half business results and narrows our guidance for 2024 full-year adjusted diluted earnings per share (EPS). "Altria's momentum continues to build as we pursue our Vision to responsibly lead the transition of adult smokers to a smoke-free future," said Billy Gifford, Altria's Chief Executive Officer. "In the second quarter, our companies' innovative smoke-free products delivered strong share and volume performance, and we hit meaningful milestones that we believe set us up for future success. NJOY received the first and only marketing granted orders from the FDA for menthol e-vapor products, and we submitted PMTA
Altria Group, Inc. (Altria) (NYSE:MO) will host a live audio webcast on Wednesday, July 31, 2024, at 9:00 a.m. Eastern Time to discuss its 2024 second-quarter and first-half business results. Altria will issue a press release containing its business results at approximately 7:00 a.m. Eastern Time the same day. The webcast can be accessed at altria.com. During the webcast, Billy Gifford, Altria's Chief Executive Officer, and Sal Mancuso, Altria's Chief Financial Officer, will discuss the Company's 2024 second-quarter and first-half business results and answer questions from the investment community and news media. The webcast will be in a listen-only mode. Pre-event registration is neces
Today, Altria Group, Inc. (Altria) announces the submission of Premarket Tobacco Product Applications (PMTAs) to the U.S. Food and Drug Administration (FDA) for its innovative on! PLUS oral nicotine pouch products. The PMTAs were submitted by Altria's wholly owned subsidiary Helix Innovations LLC (Helix). on! PLUS is a spit-free, oral tobacco-derived nicotine (TDN) pouch product made from a proprietary "soft-feel" material to provide a more comfortable product experience. The on! PLUS pouch is designed for adults who dip and adult dual users (i.e., adults who smoke and dip). on! PLUS pouches are seamless and larger than the leading U.S. TDN brands. Similar to the currently marketed on!® p
Altria Group, Inc. (Altria) (NYSE:MO) announces today that the U.S. Food and Drug Administration (FDA) issued marketing orders for NJOY ACE Pod Menthol 2.4%, NJOY ACE Pod Menthol 5%, NJOY DAILY Menthol 4.5%, and NJOY DAILY Extra Menthol 6%. These authorizations follow FDA review of the Premarket Tobacco Product Applications (PMTA), submitted by NJOY, LLC (NJOY) in March 2020. NJOY ACE remains the only pod-based e-vapor product with marketing authorization from the FDA, and now NJOY has the first and only menthol e-vapor products authorized by the FDA to date. "Altria is Moving Beyond Smoking™, taking action to transition millions of adult smokers to potentially less harmful alternatives.
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
10-Q - ALTRIA GROUP, INC. (0000764180) (Filer)
8-K - ALTRIA GROUP, INC. (0000764180) (Filer)
10-Q - ALTRIA GROUP, INC. (0000764180) (Filer)
8-K - ALTRIA GROUP, INC. (0000764180) (Filer)
11-K - ALTRIA GROUP, INC. (0000764180) (Filer)
11-K - ALTRIA GROUP, INC. (0000764180) (Filer)
10-K/A - ALTRIA GROUP, INC. (0000764180) (Filer)
8-K - ALTRIA GROUP, INC. (0000764180) (Filer)
10-Q - ALTRIA GROUP, INC. (0000764180) (Filer)
8-K - ALTRIA GROUP, INC. (0000764180) (Filer)
Jacinto J. Hernandez, a director of Altria Group, Inc. ("Altria"), retired from service on our Board of Directors effective February 23, 2024. Mr. Hernandez will continue to serve Altria as a strategic advisor under a 5-year advisory services agreement. "We thank Jacinto for his service on our Board," said Kathryn McQuade, Altria's independent Board Chair. "Our Board benefited from his industry experience and financial expertise." "I joined Altria's Board because I am inspired by Altria's Vision to responsibly lead the transition of adult smokers to a smoke-free future," said Mr. Hernandez. "I am pleased that this agreement will allow me to focus my attention on helping Altria pursue it
-Yzaguirre joins a list of seasoned professionals on FireFly's team with specific expertise in initiating and growing businesses in evolving market conditions- FireFly Automatix, Inc., the de facto industry leader in AV and EV professional turfgrass mowing technology, today announced the appointment of financial and leadership expert M. Max Yzaguirre as a strategic advisor to CEO Andrew Limpert and the board of directors. Yzaguirre's appointment follows the recent additions of former WPP Group CFO Paul Richardson and capital markets professional Liz Hocker to FireFly's board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202401
Nabil Y. Sakkab, a director of Altria Group, Inc. ("Altria") since 2008, will retire from service on our Board of Directors following the completion of his current term. Consequently, Mr. Sakkab will not stand for re-election to the Board of Directors at Altria's 2024 Annual Meeting of Shareholders, which Altria anticipates holding on May 16, 2024. "Nabil's contributions have significantly benefited Altria over the past 15 years," said Kathryn McQuade, Altria's independent Chair of the Board. "We thank him for his long and distinguished service and wish him the very best upon his retirement." Dr. Sakkab is Chair of the Innovation Committee and is a member of the Executive, Finance, and
NEW YORK, July 07, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of late-stage microdose array print (MAP™) therapeutics, today announced that it has appointed Dr. Ellen Strahlman and Dr. Ram Palanki as new and independent members of its Board of Directors. With these appointments, the Eyenovia Board will expand to eight seats, from six currently. "I could not be more pleased to welcome Drs. Strahlman and Palanki to our Board and look forward to their immediate contributions," stated Dr. Sean Ianchulev, chief executive officer and chief medical officer of Eyenovia. "Each brings decades of medical technology, cl
RICHMOND, Va.--(BUSINESS WIRE)--Altria Group, Inc. (Altria) (NYSE: MO) is participating today in the Morgan Stanley Global Consumer and Retail Conference. Billy Gifford, Altria’s Chief Executive Officer, and Sal Mancuso, Chief Financial Officer, will host virtual meetings with investors to discuss Altria's business fundamentals. 2020 Full-Year Guidance Altria reaffirms its guidance for 2020 full-year adjusted diluted earnings per share (EPS) to be in a range of $4.30 to $4.38. This range represents a growth rate of 2% to 4% from an adjusted diluted EPS base of $4.21 in 2019, as shown in Schedule 1, and excludes the special items recorded in the first nine months of 2020, also sh
Morgan Stanley initiated coverage of Altria with a rating of Equal-Weight and set a new price target of $54.00
BofA Securities upgraded Altria from Neutral to Buy and set a new price target of $65.00 from $55.00 previously
Citigroup reiterated coverage of Altria with a rating of Neutral and set a new price target of $48.00 from $44.50 previously
UBS resumed coverage of Altria with a rating of Sell
Stifel resumed coverage of Altria with a rating of Buy and set a new price target of $52.00
UBS downgraded Altria from Neutral to Sell and set a new price target of $38.00
Barclays downgraded Altria from Equal Weight to Underweight and set a new price target of $36.00 from $53.00 previously
Morgan Stanley upgraded Altria from Underweight to Equal-Weight and set a new price target of $43.00 from $47.00 previously
Morgan Stanley downgraded Altria from Equal-Weight to Underweight and set a new price target of $50.00 from $54.00 previously
Bernstein downgraded Altria from Outperform to Mkt Perform and set a new price target of $53.00 from $58.00 previously
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)